Pinnacle Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-35,630
| Closed | -$135K | – | 711 |
|
|
2020
Q1 | $135K | Sell |
35,630
-6,350
| -15% | -$24.1K | ﹤0.01% | 622 |
|
|
2019
Q4 | $214K | Sell |
41,980
-1,215,118
| -97% | -$6.19M | ﹤0.01% | 657 |
|
|
2019
Q3 | $6.36M | Sell |
1,257,098
-41,625
| -3% | -$210K | 0.15% | 166 |
|
|
2019
Q2 | $8.01M | Sell |
1,298,723
-119,668
| -8% | -$738K | 0.19% | 148 |
|
|
2019
Q1 | $6.58M | Sell |
1,418,391
-26,475
| -2% | -$123K | 0.15% | 173 |
|
|
2018
Q4 | $6.07M | Sell |
1,444,866
-85,791
| -6% | -$360K | 0.16% | 167 |
|
|
2018
Q3 | $9.6M | Sell |
1,530,657
-258,416
| -14% | -$1.62M | 0.2% | 137 |
|
|
2018
Q2 | $14.4M | Sell |
1,789,073
-312,595
| -15% | -$2.51M | 0.3% | 94 |
|
|
2018
Q1 | $15.7M | Sell |
2,101,668
-111,450
| -5% | -$831K | 0.31% | 91 |
|
|
2017
Q4 | $13.2M | Sell |
2,213,118
-171,715
| -7% | -$1.02M | 0.25% | 101 |
|
|
2017
Q3 | $17.6M | Sell |
2,384,833
-70,085
| -3% | -$516K | 0.32% | 85 |
|
|
2017
Q2 | $16.7M | Sell |
2,454,918
-98,520
| -4% | -$669K | 0.32% | 87 |
|
|
2017
Q1 | $24.1M | Sell |
2,553,438
-111,502
| -4% | -$1.05M | 0.46% | 63 |
|
|
2016
Q4 | $23M | Sell |
2,664,940
-149,600
| -5% | -$1.29M | 0.46% | 64 |
|
|
2016
Q3 | $17.8M | Sell |
2,814,540
-30,380
| -1% | -$192K | 0.36% | 84 |
|
|
2016
Q2 | $12M | Buy |
+2,844,920
| New | +$12M | 0.26% | 109 |
|